ALM-401

N/A

Report date: 2025/05/14 14:10:47

First In Class

Base Information

Drug NameALM-401

Drug Alias NameALM-401

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionAnti-Inactive tyrosine-protein kinase transmembrane receptor ROR1Anti-Epidermal growth factor receptor erbB1

TargetsInactive tyrosine-protein kinase transmembrane receptor ROR1Epidermal growth factor receptor erbB1

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAlmac Discovery Ltd

China Registration ClassN/A

Develop Information

Active CompaniesAlmac Discovery Ltd

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell Lung

Inactive IndicationsN/A

Other Information

ATC CodeN/A